In the second quarter, CVS Health topped analyst estimates although front end comparable sales slipped slightly after a 10% gain in the 2022 period. Company net income was $1.9 billion, or $1.48 per diluted share, versus $3.03 billion, or $2.29 per diluted share, in...
In the midst of reorganizing the company, CVS Health posted lower net income that was still good enough to beat a Wall Street estimate, and it recorded a front-end comp gain. Company net income was $2.14 billion, or $1.65 per diluted share, versus $2.35 billion, or...
CVS beat Wall Street estimates in its fourth quarter while its front-end comparable sales made a strong gain after increasing 18.9% in the period a year past. Company net income was $2.3 billion, or $1.75 per diluted share, versus $1.31 billion, or 98 cents per...
CVS Health has named Amy Bricker executive vp and chief product officer, consumer, a position where she will focus on consumer products and innovation, leading the development of new products that support the evolving health care needs of customers in the community,...
Third quarter earnings and income at CVS Health beat Wall Street estimates despite unadjusted losses from an opioid litigation settlement. Company net loss was $3.42 billion, or $2.60 per diluted share, versus net income of $1.6 billion, or $1.20 per diluted share, in...
